Reaction Details |
| Report a problem with these data |
Target | 5-hydroxytryptamine receptor 7 |
---|
Ligand | BDBM50130293 |
---|
Substrate/Competitor | n/a |
---|
Ki | 14.5±n/a nM |
---|
Comments | PDSP_1414 |
---|
Citation | Lawler, CP; Prioleau, C; Lewis, MM; Mak, C; Jiang, D; Schetz, JA; Gonzalez, AM; Sibley, DR; Mailman, RB Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. Neuropsychopharmacology20:612-27 (1999) [PubMed] Article |
---|
More Info.: | Get all data from this article |
---|
|
5-hydroxytryptamine receptor 7 |
---|
Name: | 5-hydroxytryptamine receptor 7 |
Synonyms: | 5-HT-7 | 5-HT-X | 5-HT7 | 5-HT7L | 5-HT7S | 5-Hydroxytryptamine receptor 7 (5-HT7) | 5-hydroxytryptamine receptor 7 | 5-hydroxytryptamine receptor 7 (5-HT-7) | 5HT7R_RAT | Adrenergic Alpha | GPRFO | Htr7 | Serotonin (5-HT) receptor | Serotonin Receptor 7 |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 49852.62 |
Organism: | Rattus norvegicus (rat) |
Description: | Rat cloned 5-HT7R. |
Residue: | 448 |
Sequence: | MMDVNSSGRPDLYGHLRSLILPEVGRGLQDLSPDGGAHPVVSSWMPHLLSGFLEVTASPA
PTWDAPPDNVSGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSN
YLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVIS
IDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDF
GYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVQPESVISLNGVVKLQK
EVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTS
CSCIPLWVERTCLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHE
ALKLAERPERSEFVLQNSDHCGKKGHDT
|
|
|
BDBM50130293 |
---|
n/a |
---|
Name | BDBM50130293 |
Synonyms: | 7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one | ARIPIPRAZOLE | CHEMBL1112 | US10174011, aripiprazole | US10752588, Compound Aripiprazole | US11498896, Compound Aripiprazole | US9018213, aripprazole | US9156822, Aripiprazole |
Type | Small organic molecule |
Emp. Form. | C23H27Cl2N3O2 |
Mol. Mass. | 448.385 |
SMILES | Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl |
Structure |
|